Bukola Ajanaku

Bukola Ajanaku

Auto-generated profile, based on publicly available information

Bukola Ajanaku

Icahn School of Medicine at Mount Sinai

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EYEge A. Yalcinbas
Ege A. Yalcinbas
BABukola Ajanaku
Bukola Ajanaku
ENErik D. Nelson
Erik D. Nelson
RGRenee Garcia-Flores
Renee Garcia-Flores
NENicholas J. Eagles
Nicholas J. Eagles
KMKristen R. Maynard
Kristen R. Maynard
Pathophysiology of many neuropsychiatric disorders, including schizophrenia (SCZD), is linked to habenula (Hb) function. While pharmacotherapies and deep brain stimulation targeting the Hb are emerging as promising therapeutic treatments, little is known about the cell type-specific transcriptomic organization of the human Hb or how it is altered in SCZD. Here we define the molecular neuroanatomy of the human Hb and identify transcriptomic changes in individuals with SCZD compared to neurotypical controls. Utilizing Hb-enriched postmortem human brain tissue, we performed single nucleus RNA-sequencing (snRNA-seq; n=7 neurotypical donors) and identified 17 molecularly defined Hb cell types across 16,437 nuclei, including 3 medial and 7 lateral Hb populations, several of which were conserved between rodents and humans. Single molecule fluorescent in situ hybridization (smFISH; n=3 neurotypical donors) validated snRNA-seq Hb cell types and mapped their spatial locations. Bulk RNA-sequencing and cell type deconvolution in Hb-enriched tissue from 35 individuals with SCZD and 33 neurotypical controls yielded 45 SCZD-associated differentially expressed genes (DEGs, FDR < 0.05), with 32 (71%) unique to Hb-enriched tissue. eQTL analysis identified 717 independent SNP-gene pairs (FDR < 0.05), where either the SNP is a SCZD risk variant (16 pairs) or the gene is a SCZD DEG (7 pairs). eQTL and SCZD risk colocalization analysis identified 16 colocalized genes. These results identify topographically organized cell types with distinct molecular signatures in the human Hb and demonstrate unique genetic changes associated with SCZD, thereby providing novel molecular insights into the role of Hb in neuropsychiatric disorders. One Sentence Summary: Transcriptomic analysis of the human habenula and identification of molecular changes associated with schizophrenia risk and illness state.

5 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SVSanan Venkatesh
Sanan Venkatesh
ZWZhenyi Wu
Zhenyi Wu
MAMarios Anyfantakis
Marios Anyfantakis
CDChristian Dillard
Christian Dillard
PMPrashant N M
Prashant N M
Panos RoussosPanos Roussos
Panos Roussos
Neuropsychiatric and neurodegenerative disorders exhibit cell-type-specific characteristics 1–8 , yet most transcriptome-wide association studies have been constrained by the use of homogenate brain tissue 9–11 , limiting their resolution and power. Here, we present a single-nucleus transcriptome-wide association study ( snTWAS ) leveraging single-nucleus RNA sequencing of over 6 million nuclei from the dorsolateral prefrontal cortex of 1,494 donors across three ancestries—European, African, and Admixed American. We constructed ancestry-specific single-nucleus-derived transcriptomic imputation models ( snTIMs ) including up to 27 non-overlapping cellular populations, enhancing the resolution of genetically regulated gene expression ( GReX ) in the brain and uncovering novel gene-trait associations across 12 neuropsychiatric and neurodegenerative traits. Our snTWAS framework revealed cell-type-specific dysregulation of GReX, identifying over 4,000 novel gene-trait associations not detected by bulk tissue approaches. By applying these snTIMs to the Million Veteran Program, we validated major findings and explored the pleiotropy of cell-type-specific GReX, revealing cross-ancestry concordance and fine-mapping causal genes. This approach enhances the discovery of biologically relevant pathways and gene targets, highlighting the importance of cell-type resolution and ancestry-specific models in understanding the genetic architecture of complex brain disorders.